Insulet
PODD
#1041
Rank
HK$143.52 B
Marketcap
HK$2,046
Share price
-0.81%
Change (1 day)
25.10%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2024 (TTM): HK$2.63 Billion

According to Insulet's latest financial reports the company's current earnings are HK$1.98 Billion. In 2023 the company made an earning of HK$1.94 Billion, an increase over its 2022 earnings that were of HK$0.33 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) HK$2.63 B35.1%
2023 HK$1.94 B481.9%
2022 HK$0.33 B-45.24%
2021 HK$0.61 B43.35%
2020 HK$0.42 B18.51%
2019 HK$0.35 B41.16%
2018 HK$0.25 B-711.95%
2017 -HK$41.67 Million-56.85%
2016 -HK$96.58 Million-79.31%
2015 -HK$0.47 Billion63.85%
2014 -HK$0.29 Billion31.04%
2013 -HK$0.22 Billion-21.96%
2012 -HK$0.28 Billion
2010 -HK$0.27 Billion-42.38%
2009 -HK$0.47 Billion-33.56%
2008 -HK$0.7 Billion65.93%
2007 -HK$0.42 Billion209.75%
2006 -HK$0.14 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-HK$29.93 Million-101.14%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$0.97 Billion-136.81%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$5.92 B 126.11%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$142.92 B 5,351.99%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$52.66 B 1,908.89%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$45.99 B 1,654.59%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
HK$78.86 B 2,908.45%๐Ÿ‡บ๐Ÿ‡ธ USA